RecallHawk

LUPRON DEPOT (LEUPROLIDE ACETATE)

ABBVIE ENDOCRINE INC

Summary

FDA approved LUPRON DEPOT (LEUPROLIDE ACETATE) by ABBVIE ENDOCRINE INC. NDA (New Drug) approval (Labeling) on 2025-08-18. INJECTABLE, INJECTION.

Details

Source

Drug Approval

External ID

NDA019732-50

Action Date

2025-08-18

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

LUPRON DEPOT (generic: LEUPROLIDE ACETATE), INJECTABLE, INJECTION. Application: NDA019732

Context & Analysis

ABBVIE ENDOCRINE INC has 3 FDA actions in our database.

Frequently Asked Questions

How often does ABBVIE ENDOCRINE INC have FDA actions?

ABBVIE ENDOCRINE INC has 3 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA019732-50" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions